TimeTeller puts our internal clocks at the center of personalized medicine

German startup TimeTeller is advancing the field of personalized medicine with the introduction of a new saliva test kit designed to analyze an individual's circadian rhythm. By measuring internal biological clocks, the company aims to provide actionable insights that can significantly improve medical outcomes, particularly in oncology. The primary goal of the technology is to help clinicians optimize the timing of treatments, thereby reducing the severity of side effects associated with cancer therapies. By aligning medical interventions with a patient's unique biological timing, TimeTeller hopes to make treatments more effective and tolerable. This development marks a significant step forward in biotech, as it shifts the focus toward chronobiology as a key component of patient care. The startup is currently working to integrate these findings into clinical workflows, potentially setting a new standard for how personalized treatment plans are developed and executed in the future.